Skip to main content
Erschienen in: Archives of Virology 7/2013

01.07.2013 | Brief Review

An update on viral association of human cancers

verfasst von: Xiangning Zhang, Zhe Zhang, Biying Zheng, Zhiwei He, Gösta Winberg, Ingemar Ernberg

Erschienen in: Archives of Virology | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

Up to now, seven viruses that infect humans have been identified as oncogenic and are closely associated with different human cancers. Most of them encode oncogenes whose products play important roles in the development of cancers in the context of environmental and genetic factors; others may act via indirect mechanisms. The transforming activities of the human oncogenic viruses have much in common with the well-studied tumorigenic processes elicited by the acutely transforming murine retroviruses. Many of these mechanisms have been elucidated for or are represented in the successive steps leading to the efficient in vitro immortalization by the lymphotropic herpesvirus Epstein-Barr virus, although the establishment of malignancy in vivo takes longer. The development of cancer is a complicated process involving multiple factors, from the host and the environment. Although any one of these etiologic factors may exert an effect on the carcinogenic process, vaccination against the viral pathogen in several cases has shown efficacy in preventing the spread of the virus and, in turn, the development of the associated cancers. Modern laboratory techniques can be expected to facilitate the identification of new emerging viruses whose association with malignancies is suggested by epidemiologic and clinical data.
Literatur
1.
Zurück zum Zitat Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266:1865–1869PubMedCrossRef Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266:1865–1869PubMedCrossRef
2.
Zurück zum Zitat Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P (1995) A role for a new herpes virus (KSHV) in different forms of Kaposi’s sarcoma. Nat Med 1:707–708PubMedCrossRef Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P (1995) A role for a new herpes virus (KSHV) in different forms of Kaposi’s sarcoma. Nat Med 1:707–708PubMedCrossRef
3.
Zurück zum Zitat Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM (1995) Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186–1191PubMedCrossRef Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM (1995) Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186–1191PubMedCrossRef
4.
Zurück zum Zitat Feng H, Shuda M, Chang Y, Moore PS (2008) Clonal integration of a polyomavirus in human merkel cell carcinoma. Science 319:1096–1100PubMedCrossRef Feng H, Shuda M, Chang Y, Moore PS (2008) Clonal integration of a polyomavirus in human merkel cell carcinoma. Science 319:1096–1100PubMedCrossRef
5.
Zurück zum Zitat Rous P (1911) A Sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 13:397–411PubMedCrossRef Rous P (1911) A Sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 13:397–411PubMedCrossRef
6.
Zurück zum Zitat Zheng ZM (2010) Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci 6:730–755PubMedCrossRef Zheng ZM (2010) Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci 6:730–755PubMedCrossRef
7.
Zurück zum Zitat Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J (2003) Seroepidemiology of the human polyomaviruses. J Gen Virol 84:1499–1504PubMedCrossRef Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J (2003) Seroepidemiology of the human polyomaviruses. J Gen Virol 84:1499–1504PubMedCrossRef
8.
Zurück zum Zitat Barbanti-Brodano G, Sabbioni S, Martini F, Negrini M, Corallini A, Tognon M (2006) BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. Adv Exp Med Biol 577:319–341PubMedCrossRef Barbanti-Brodano G, Sabbioni S, Martini F, Negrini M, Corallini A, Tognon M (2006) BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. Adv Exp Med Biol 577:319–341PubMedCrossRef
9.
Zurück zum Zitat zur Hausen H (2008) Novel human polyomaviruses—Re-emergence of a well known virus family as possible human carcinogens. Int J Cancer 123:247–250PubMedCrossRef zur Hausen H (2008) Novel human polyomaviruses—Re-emergence of a well known virus family as possible human carcinogens. Int J Cancer 123:247–250PubMedCrossRef
10.
Zurück zum Zitat Allander T, Andreasson K, Gupta S, Bjerkner A, Bogdanovic G, Persson MAA, Dalianis T, Ramqvist T, Andersson B (2007) Identification of a third human polyomavirus. J Virol 81:4130–4136PubMedCrossRef Allander T, Andreasson K, Gupta S, Bjerkner A, Bogdanovic G, Persson MAA, Dalianis T, Ramqvist T, Andersson B (2007) Identification of a third human polyomavirus. J Virol 81:4130–4136PubMedCrossRef
11.
Zurück zum Zitat Gaynor AM, Nissen MD, Whiley DM, Mackay IM, Lambert SB et al (2007) Identification of a novel polyomavirus from patients with acute respiratory tract infections. Plos Pathog 3:595–604CrossRef Gaynor AM, Nissen MD, Whiley DM, Mackay IM, Lambert SB et al (2007) Identification of a novel polyomavirus from patients with acute respiratory tract infections. Plos Pathog 3:595–604CrossRef
12.
Zurück zum Zitat Helmbold P, Lahtz C, Enk A, Herrmann-Trost P, Marsch WCh, Kutzner H, Dammann RH (2009) Frequent occurrence of RASSF1A promoter hypermethylation and Merkel cell polyomavirus in Merkel cell carcinoma. Mol Carcinog 48:903–909PubMedCrossRef Helmbold P, Lahtz C, Enk A, Herrmann-Trost P, Marsch WCh, Kutzner H, Dammann RH (2009) Frequent occurrence of RASSF1A promoter hypermethylation and Merkel cell polyomavirus in Merkel cell carcinoma. Mol Carcinog 48:903–909PubMedCrossRef
13.
Zurück zum Zitat Sastre-Garau X, Peter M, Avril MF, Laude H, Couturier J, Rozenberg F, Almeida A, Boitier F, Carlotti A, Couturaud B, Dupin N (2009) Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis. J Pathol 218:48–56PubMedCrossRef Sastre-Garau X, Peter M, Avril MF, Laude H, Couturier J, Rozenberg F, Almeida A, Boitier F, Carlotti A, Couturaud B, Dupin N (2009) Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis. J Pathol 218:48–56PubMedCrossRef
14.
Zurück zum Zitat de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324:17–27PubMedCrossRef de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324:17–27PubMedCrossRef
17.
Zurück zum Zitat Lo EJ, Bell D, Woo JS, Li G, Hanna EY, El-Naggar AK, Sturgis EM (2010) Human papillomavirus and WHO type I nasopharyngeal carcinoma. Laryngoscope 120:1990–1997PubMedCrossRef Lo EJ, Bell D, Woo JS, Li G, Hanna EY, El-Naggar AK, Sturgis EM (2010) Human papillomavirus and WHO type I nasopharyngeal carcinoma. Laryngoscope 120:1990–1997PubMedCrossRef
18.
Zurück zum Zitat Laantri N, Attaleb M, Kandil M, Naji F, Mouttaki T, Dardari R, Belghmi K, Benchakroun N, El Mzibri M, Khyatti M (2011) Human papillomavirus detection in moroccan patients with nasopharyngeal carcinoma. Infect Agent Cancer 6:3PubMedCrossRef Laantri N, Attaleb M, Kandil M, Naji F, Mouttaki T, Dardari R, Belghmi K, Benchakroun N, El Mzibri M, Khyatti M (2011) Human papillomavirus detection in moroccan patients with nasopharyngeal carcinoma. Infect Agent Cancer 6:3PubMedCrossRef
19.
Zurück zum Zitat Huang CC, Hsiao JR, Yang MW, Wu YH, Hsu KF, Chang Y, Chen CW, Tsai ST, Wei HP, Jin YT (2011) Human papilloma virus detection in neoplastic and non-neoplastic nasopharyngeal tissues in Taiwan. J Clin Pathol 64:571–577PubMedCrossRef Huang CC, Hsiao JR, Yang MW, Wu YH, Hsu KF, Chang Y, Chen CW, Tsai ST, Wei HP, Jin YT (2011) Human papilloma virus detection in neoplastic and non-neoplastic nasopharyngeal tissues in Taiwan. J Clin Pathol 64:571–577PubMedCrossRef
20.
Zurück zum Zitat Chen TH, Huang CC, Yeh KT, Chang SH, Chang SW, Sung WW, Cheng YW, Lee H (2012) Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer. World J Gastroenterol 18:4051–4058PubMedCrossRef Chen TH, Huang CC, Yeh KT, Chang SH, Chang SW, Sung WW, Cheng YW, Lee H (2012) Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer. World J Gastroenterol 18:4051–4058PubMedCrossRef
21.
Zurück zum Zitat Vousden KH, Jat PS (1989) Functional similarity between HPV16E7, SV40 large T and adenovirus E1a proteins. Oncogene 4:153–158PubMed Vousden KH, Jat PS (1989) Functional similarity between HPV16E7, SV40 large T and adenovirus E1a proteins. Oncogene 4:153–158PubMed
22.
Zurück zum Zitat Liu X, Clements A, Zhao K, Marmorstein R (2006) Structure of the human papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor. J Biol Chem 281:578–586PubMedCrossRef Liu X, Clements A, Zhao K, Marmorstein R (2006) Structure of the human papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor. J Biol Chem 281:578–586PubMedCrossRef
23.
24.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90PubMedCrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90PubMedCrossRef
25.
Zurück zum Zitat Perz JF, Armstrong GL, Farrington LA et al (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45:529–538PubMedCrossRef Perz JF, Armstrong GL, Farrington LA et al (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45:529–538PubMedCrossRef
26.
Zurück zum Zitat Bouchard MJ, Schneider RJ (2004) The enigmatic X gene of hepatitis B virus. J Virol 78:12725–12734PubMedCrossRef Bouchard MJ, Schneider RJ (2004) The enigmatic X gene of hepatitis B virus. J Virol 78:12725–12734PubMedCrossRef
27.
Zurück zum Zitat Yen CJ, Lin YJ, Yen CS, Tsai HW, Tsai TF, Chang KY, Huang WC, Lin PW, Chiang CW, Chang TT (2012) Hepatitis B Virus X Protein Upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma. PLoS One 7(7):e41931PubMedCrossRef Yen CJ, Lin YJ, Yen CS, Tsai HW, Tsai TF, Chang KY, Huang WC, Lin PW, Chiang CW, Chang TT (2012) Hepatitis B Virus X Protein Upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma. PLoS One 7(7):e41931PubMedCrossRef
28.
Zurück zum Zitat Diao J, Garces R, Richardson CD (2001) X protein of hepatitis B virus modulates Cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev 12:189–205PubMedCrossRef Diao J, Garces R, Richardson CD (2001) X protein of hepatitis B virus modulates Cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev 12:189–205PubMedCrossRef
29.
Zurück zum Zitat Kuzhandaivelu N, Cong YS, Inouye C, Yang WM, Seto E (1996) XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation. Nucleic Acids Res 24:4741–4750PubMedCrossRef Kuzhandaivelu N, Cong YS, Inouye C, Yang WM, Seto E (1996) XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation. Nucleic Acids Res 24:4741–4750PubMedCrossRef
30.
Zurück zum Zitat Kashuba E, Kashuba V, Pokrovskaja K, Klein G, Szekely L (2000) Epstein–Barr virus encoded nuclear protein EBNA-3 binds XAP-2, a protein associated with Hepatitis B virus X antigen. Oncogene 19:1801–1806PubMedCrossRef Kashuba E, Kashuba V, Pokrovskaja K, Klein G, Szekely L (2000) Epstein–Barr virus encoded nuclear protein EBNA-3 binds XAP-2, a protein associated with Hepatitis B virus X antigen. Oncogene 19:1801–1806PubMedCrossRef
31.
Zurück zum Zitat Liu J, Lian Z, Han S et al (2006) De-regulation of E-Cadherin by hepatitis B virus × antigen in hepatocellular carcinoma. Oncogene 16:1008–1017CrossRef Liu J, Lian Z, Han S et al (2006) De-regulation of E-Cadherin by hepatitis B virus × antigen in hepatocellular carcinoma. Oncogene 16:1008–1017CrossRef
32.
Zurück zum Zitat Zhang X, Dong N, Zhang H et al (2005) Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells. J Lab Clin Med 145:96–104CrossRef Zhang X, Dong N, Zhang H et al (2005) Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells. J Lab Clin Med 145:96–104CrossRef
33.
Zurück zum Zitat Poussin K, Dienes H, Sirma H et al (1999) Expression of mutated Hepatitis B virus X genes in human hepatocellular carcinomas. Int J Cancer 192:111–118 Poussin K, Dienes H, Sirma H et al (1999) Expression of mutated Hepatitis B virus X genes in human hepatocellular carcinomas. Int J Cancer 192:111–118
34.
Zurück zum Zitat Wang Y, Lau SH, Sham JST et al (2004) Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated x gene and hepatocellular carcinogenesis. Oncogene 23:142–148PubMedCrossRef Wang Y, Lau SH, Sham JST et al (2004) Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated x gene and hepatocellular carcinogenesis. Oncogene 23:142–148PubMedCrossRef
35.
Zurück zum Zitat Sze KM, Chu GK, Lee JM, Ng IO (2012) C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by c-jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma. Hepatology 57:131–139 Sze KM, Chu GK, Lee JM, Ng IO (2012) C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by c-jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma. Hepatology 57:131–139
36.
Zurück zum Zitat Wang C, Yang W, Yan HX, Luo T, Zhang J, Tang L, Wu FQ, Zhang HL, Yu LX, Zheng LY, Li YQ, Dong W, He YQ, Liu Q, Zou SS, Lin Y, Hu L, Li Z, Wu MC, Wang HY (2012) Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice. Hepatology 55:108–120PubMedCrossRef Wang C, Yang W, Yan HX, Luo T, Zhang J, Tang L, Wu FQ, Zhang HL, Yu LX, Zheng LY, Li YQ, Dong W, He YQ, Liu Q, Zou SS, Lin Y, Hu L, Li Z, Wu MC, Wang HY (2012) Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice. Hepatology 55:108–120PubMedCrossRef
37.
Zurück zum Zitat Liang TJ, Heller T (2004) Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology 127:S62–S71PubMedCrossRef Liang TJ, Heller T (2004) Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology 127:S62–S71PubMedCrossRef
38.
Zurück zum Zitat Jopling CL, Yi M, Lancaster AM et al (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309:1577–1581PubMedCrossRef Jopling CL, Yi M, Lancaster AM et al (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309:1577–1581PubMedCrossRef
39.
Zurück zum Zitat Zhong J, Gastaminza P, Chung J, Stamataki Z, Isogawa M, Cheng G, McKeating JA, Chisari FV (2006) Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J. Virol. 80:11082–11093PubMedCrossRef Zhong J, Gastaminza P, Chung J, Stamataki Z, Isogawa M, Cheng G, McKeating JA, Chisari FV (2006) Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J. Virol. 80:11082–11093PubMedCrossRef
41.
Zurück zum Zitat Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297PubMedCrossRef Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297PubMedCrossRef
42.
Zurück zum Zitat Samols MA, Renne R (2006) Virus-encoded microRNAs: a new chapter in virus-host cell interaction. Future Virol 1:233–242CrossRef Samols MA, Renne R (2006) Virus-encoded microRNAs: a new chapter in virus-host cell interaction. Future Virol 1:233–242CrossRef
44.
Zurück zum Zitat Cai X, Schafer A, Lu S, Bilello JP, Desrosiers RC, Edwards R, Raab-Traub N, Cullen BR (2006) Epstein–Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2:e23PubMedCrossRef Cai X, Schafer A, Lu S, Bilello JP, Desrosiers RC, Edwards R, Raab-Traub N, Cullen BR (2006) Epstein–Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2:e23PubMedCrossRef
45.
Zurück zum Zitat Grundhoff A, Sullivan CS, Ganem D (2006) A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12:733–750PubMedCrossRef Grundhoff A, Sullivan CS, Ganem D (2006) A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12:733–750PubMedCrossRef
46.
Zurück zum Zitat Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, Tuschl T (2004) Identification of virus-encoded microRNAs. Science 304:734–736PubMedCrossRef Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, Tuschl T (2004) Identification of virus-encoded microRNAs. Science 304:734–736PubMedCrossRef
47.
Zurück zum Zitat Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR (2005) Kaposi’s sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci USA 102:5570–5575PubMedCrossRef Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR (2005) Kaposi’s sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci USA 102:5570–5575PubMedCrossRef
48.
Zurück zum Zitat Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, Grasser FA, van Dyk LF, Ho CK, Shuman S, Chien M, Russo JJ, Ju J, Randall G, Lindenbach BD, Rice CM, Simon V, Ho DD, Zavolan M, Tuschl T (2005) Identification of microRNAs of the herpesvirus family. Nat Methods 2:269–276PubMedCrossRef Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, Grasser FA, van Dyk LF, Ho CK, Shuman S, Chien M, Russo JJ, Ju J, Randall G, Lindenbach BD, Rice CM, Simon V, Ho DD, Zavolan M, Tuschl T (2005) Identification of microRNAs of the herpesvirus family. Nat Methods 2:269–276PubMedCrossRef
49.
Zurück zum Zitat Samols MA, Hu J, Skalsky RL, Renne R (2005) Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi’s sarcoma-associated herpesvirus. J Virol 79:9301–9305PubMedCrossRef Samols MA, Hu J, Skalsky RL, Renne R (2005) Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi’s sarcoma-associated herpesvirus. J Virol 79:9301–9305PubMedCrossRef
50.
Zurück zum Zitat Cai X, Hagedorn CH, Cullen BR (2004) Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10:1957–1966PubMedCrossRef Cai X, Hagedorn CH, Cullen BR (2004) Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10:1957–1966PubMedCrossRef
51.
Zurück zum Zitat Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ (2004) Processing of primary microRNAs by the Microprocessor complex. Nature 432:231–235PubMedCrossRef Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ (2004) Processing of primary microRNAs by the Microprocessor complex. Nature 432:231–235PubMedCrossRef
52.
Zurück zum Zitat Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N et al (2004) The Microprocessor complex mediates the genesis of microRNAs. Nature 432:235–240PubMedCrossRef Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N et al (2004) The Microprocessor complex mediates the genesis of microRNAs. Nature 432:235–240PubMedCrossRef
53.
Zurück zum Zitat Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J et al (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425:415–419PubMedCrossRef Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J et al (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425:415–419PubMedCrossRef
54.
Zurück zum Zitat Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee JK et al (2006) Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 125:887–901PubMedCrossRef Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee JK et al (2006) Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 125:887–901PubMedCrossRef
55.
Zurück zum Zitat Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U (2004) Nuclear export of microRNA precursors. Science 303:95–98PubMedCrossRef Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U (2004) Nuclear export of microRNA precursors. Science 303:95–98PubMedCrossRef
56.
Zurück zum Zitat Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD (2001) A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293:834–838PubMedCrossRef Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD (2001) A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293:834–838PubMedCrossRef
57.
Zurück zum Zitat Salzman DW, Shubert-Coleman J, Furneaux H (2007) P68 RNA helicase unwinds the human let-7 microRNA precursor duplex and is required for let-7-directed silencing of gene expression. J Biol Chem 282:32773–32779PubMedCrossRef Salzman DW, Shubert-Coleman J, Furneaux H (2007) P68 RNA helicase unwinds the human let-7 microRNA precursor duplex and is required for let-7-directed silencing of gene expression. J Biol Chem 282:32773–32779PubMedCrossRef
58.
Zurück zum Zitat Khvorova A, Reynolds A, Jayasena SD (2003) Functional siRNAs and miRNAs exhibit strand bias. Cell 115:209–216PubMedCrossRef Khvorova A, Reynolds A, Jayasena SD (2003) Functional siRNAs and miRNAs exhibit strand bias. Cell 115:209–216PubMedCrossRef
59.
Zurück zum Zitat Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD (2003) Asymmetry in the assembly of the RNAi enzyme complex. Cell 115:199–208PubMedCrossRef Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD (2003) Asymmetry in the assembly of the RNAi enzyme complex. Cell 115:199–208PubMedCrossRef
60.
Zurück zum Zitat Skalsky RL, Samols MA, Karlie B, Plaisance KB, Boss IW, Riva A, Lopez MC, Baker HV, Renne R (2007) Kaposi’s Sarcoma-Associated Herpesvirus Encodes an Ortholog of miR-155. J Virol 81:12836–12845PubMedCrossRef Skalsky RL, Samols MA, Karlie B, Plaisance KB, Boss IW, Riva A, Lopez MC, Baker HV, Renne R (2007) Kaposi’s Sarcoma-Associated Herpesvirus Encodes an Ortholog of miR-155. J Virol 81:12836–12845PubMedCrossRef
61.
Zurück zum Zitat Louafi F, Martinez-Nunez RT, Sanchez-Elsner T (2010) MicroRNA-155 targets SMAD2and modulates the response of macrophages to transforming growth factor-{beta}. J Biol Chem 285:41328–41336PubMedCrossRef Louafi F, Martinez-Nunez RT, Sanchez-Elsner T (2010) MicroRNA-155 targets SMAD2and modulates the response of macrophages to transforming growth factor-{beta}. J Biol Chem 285:41328–41336PubMedCrossRef
62.
Zurück zum Zitat Rai D, Kim SW, McKeller MR, Dahia PL, Aguiar RC (2010) Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc Natl Acad Sci USA 107:3111–3116PubMedCrossRef Rai D, Kim SW, McKeller MR, Dahia PL, Aguiar RC (2010) Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc Natl Acad Sci USA 107:3111–3116PubMedCrossRef
63.
Zurück zum Zitat Yin Q et al (2008) MicroRNA-155 is an Epstein–Barr virus-induced gene that modulates Epstein–Barr virus-regulated gene expression pathways. J Virol 82:5295–5306PubMedCrossRef Yin Q et al (2008) MicroRNA-155 is an Epstein–Barr virus-induced gene that modulates Epstein–Barr virus-regulated gene expression pathways. J Virol 82:5295–5306PubMedCrossRef
64.
Zurück zum Zitat Yin Q et al (2010) MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein–Barr virus reactivation. J Virol 84:6318–6327PubMedCrossRef Yin Q et al (2010) MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein–Barr virus reactivation. J Virol 84:6318–6327PubMedCrossRef
65.
Zurück zum Zitat Liu Y et al (2012) Kaposi’s Sarcoma-Associated Herpesvirus-Encoded MicroRNA miR-K12-11 Attenuates Transforming Growth Factor Beta Signaling through Suppression of SMAD5. J Virol 86:1372PubMedCrossRef Liu Y et al (2012) Kaposi’s Sarcoma-Associated Herpesvirus-Encoded MicroRNA miR-K12-11 Attenuates Transforming Growth Factor Beta Signaling through Suppression of SMAD5. J Virol 86:1372PubMedCrossRef
66.
Zurück zum Zitat Cahir-McFarland ED, Davidson DM, Schauer SL, Duong J, Kieff E (2000) NF-kappa B inhibition causes spontaneous apoptosis in Epstein–Barr virus-transformed lymphoblastoid cells. Proc Natl Acad Sci USA 97:6055–6060PubMedCrossRef Cahir-McFarland ED, Davidson DM, Schauer SL, Duong J, Kieff E (2000) NF-kappa B inhibition causes spontaneous apoptosis in Epstein–Barr virus-transformed lymphoblastoid cells. Proc Natl Acad Sci USA 97:6055–6060PubMedCrossRef
67.
Zurück zum Zitat Allday MJ (2009) How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt’s lymphoma? Semin Cancer Biol 19:366–376PubMedCrossRef Allday MJ (2009) How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt’s lymphoma? Semin Cancer Biol 19:366–376PubMedCrossRef
68.
69.
Zurück zum Zitat Chen J, Fu L, Zhang LY, Kwong DL, Yan L, Guan XY (2012) Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinoma. Chin J Cancer 31:215–222PubMedCrossRef Chen J, Fu L, Zhang LY, Kwong DL, Yan L, Guan XY (2012) Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinoma. Chin J Cancer 31:215–222PubMedCrossRef
70.
Zurück zum Zitat Lo KW, Kwong J, Hui AB, Chan SY, To KF, Chan AS, Chow LS, Teo PM, Johnson PJ, Huang DP (2001) High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 61:3877–3881PubMed Lo KW, Kwong J, Hui AB, Chan SY, To KF, Chan AS, Chow LS, Teo PM, Johnson PJ, Huang DP (2001) High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 61:3877–3881PubMed
71.
Zurück zum Zitat Qiu GH, Tan LK, Loh KS, Lim CY, Srivastava G, Tsai ST, Tsao SW, Tao Q (2004) The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene 23:4793–4806PubMedCrossRef Qiu GH, Tan LK, Loh KS, Lim CY, Srivastava G, Tsai ST, Tsao SW, Tao Q (2004) The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene 23:4793–4806PubMedCrossRef
72.
Zurück zum Zitat Ying J, Li H, Seng TJ, Langford C, Srivastava G, Tsao SW, Putti T, Murray P, Chan AT, Tao Q (2006) Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 25:1070–1080PubMedCrossRef Ying J, Li H, Seng TJ, Langford C, Srivastava G, Tsao SW, Putti T, Murray P, Chan AT, Tao Q (2006) Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 25:1070–1080PubMedCrossRef
73.
Zurück zum Zitat Du C, Huang T, Sun D, Mo Y, Feng H, Zhou X, Xiao X, Yu N, Hou B, Huang G, Ernberg I, Zhang Z (2011) CDH4 as a novel putative tumor suppressor gene epigenetically silenced by promoter hypermethylation in nasopharyngeal carcinoma. Cancer Lett 309:54–61PubMedCrossRef Du C, Huang T, Sun D, Mo Y, Feng H, Zhou X, Xiao X, Yu N, Hou B, Huang G, Ernberg I, Zhang Z (2011) CDH4 as a novel putative tumor suppressor gene epigenetically silenced by promoter hypermethylation in nasopharyngeal carcinoma. Cancer Lett 309:54–61PubMedCrossRef
74.
Zurück zum Zitat Zhang X, Liu H, Li B, Huang P, Shao J, He Z (2012) Tumor suppressor BLU inhibits proliferation of nasopharyngeal carcinoma cells by regulation of cell cycle, c-Jun N-terminal kinase and the cyclin D1 promoter. BMC Cancer 12:267. doi:10.1186/1471-2407-12-267 PubMedCrossRef Zhang X, Liu H, Li B, Huang P, Shao J, He Z (2012) Tumor suppressor BLU inhibits proliferation of nasopharyngeal carcinoma cells by regulation of cell cycle, c-Jun N-terminal kinase and the cyclin D1 promoter. BMC Cancer 12:267. doi:10.​1186/​1471-2407-12-267 PubMedCrossRef
75.
Zurück zum Zitat Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB (1988) Epstein–Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69:1051–1065PubMedCrossRef Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB (1988) Epstein–Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69:1051–1065PubMedCrossRef
76.
Zurück zum Zitat Pathmanathan R, Prasad U et al (1995) Clonal proliferations of cells infected with Epstein–Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333:693–698PubMedCrossRef Pathmanathan R, Prasad U et al (1995) Clonal proliferations of cells infected with Epstein–Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333:693–698PubMedCrossRef
77.
Zurück zum Zitat Pak MW, To KF et al (2002) Nasopharyngeal carcinoma in situ (NPCIS)—pathologic and clinical perspectives. Head Neck 24:989–995PubMedCrossRef Pak MW, To KF et al (2002) Nasopharyngeal carcinoma in situ (NPCIS)—pathologic and clinical perspectives. Head Neck 24:989–995PubMedCrossRef
78.
Zurück zum Zitat Cheung FM, Pang SW et al (2004) Nasopharyngeal intraepithelial lesion: latent Epstein–Barr virus infection with malignant potential. Histopathology 45:171–179PubMedCrossRef Cheung FM, Pang SW et al (2004) Nasopharyngeal intraepithelial lesion: latent Epstein–Barr virus infection with malignant potential. Histopathology 45:171–179PubMedCrossRef
79.
Zurück zum Zitat Chan AS, To KF et al (2000) High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res 60:5365–5370PubMed Chan AS, To KF et al (2000) High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res 60:5365–5370PubMed
80.
Zurück zum Zitat Chan AS, To KF et al (2002) Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese. Int J Cancer 102:300–303PubMedCrossRef Chan AS, To KF et al (2002) Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese. Int J Cancer 102:300–303PubMedCrossRef
81.
Zurück zum Zitat Liu XQ, Chen HK et al (2003) Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma. Int J Cancer 106:60–65PubMedCrossRef Liu XQ, Chen HK et al (2003) Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma. Int J Cancer 106:60–65PubMedCrossRef
82.
Zurück zum Zitat Chow LS, Lo KW et al (2004) RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. Int J Cancer 109:839–847PubMedCrossRef Chow LS, Lo KW et al (2004) RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. Int J Cancer 109:839–847PubMedCrossRef
83.
Zurück zum Zitat Raab-Traub N (2002) Epstein–Barr virus in the pathogenesis of NPC. Semin Cancer Biol 12(6):431–441PubMedCrossRef Raab-Traub N (2002) Epstein–Barr virus in the pathogenesis of NPC. Semin Cancer Biol 12(6):431–441PubMedCrossRef
84.
Zurück zum Zitat Hu L, Troyanovsky B, Zhang X, Trivedi P, Ernberg I, Klein G (2000) Differences in the immunogenicity of latent membrane protein 1(LMP1) encoded by Epstein–Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma. Cancer Res 60:5589–5593PubMed Hu L, Troyanovsky B, Zhang X, Trivedi P, Ernberg I, Klein G (2000) Differences in the immunogenicity of latent membrane protein 1(LMP1) encoded by Epstein–Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma. Cancer Res 60:5589–5593PubMed
85.
Zurück zum Zitat Zhang X, Dawson CW, He Z, Huang P (2012) Immune evasion strategies of the human gamma-herpesviruses: implications for viral tumorigenesis. J Med Virol 84:272–281PubMedCrossRef Zhang X, Dawson CW, He Z, Huang P (2012) Immune evasion strategies of the human gamma-herpesviruses: implications for viral tumorigenesis. J Med Virol 84:272–281PubMedCrossRef
86.
Zurück zum Zitat Li HM, Zhuang ZH, Wang Q, Pang JC, Wang XH, Wong HL, Feng HC, Jin DY, Ling MT, Wong YC, Eliopoulos AG, Young LS, Huang DP, Tsao SW (2004) Epstein–Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells. Oncogene 23:4488–4494PubMedCrossRef Li HM, Zhuang ZH, Wang Q, Pang JC, Wang XH, Wong HL, Feng HC, Jin DY, Ling MT, Wong YC, Eliopoulos AG, Young LS, Huang DP, Tsao SW (2004) Epstein–Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells. Oncogene 23:4488–4494PubMedCrossRef
87.
Zurück zum Zitat Lo AK et al (2010) Upregulation of Id1 by Epstein–Barr virus-encoded LMP1 confers resistance to TGFbeta-mediated growth inhibition. Mol Cancer 9:155PubMedCrossRef Lo AK et al (2010) Upregulation of Id1 by Epstein–Barr virus-encoded LMP1 confers resistance to TGFbeta-mediated growth inhibition. Mol Cancer 9:155PubMedCrossRef
88.
Zurück zum Zitat Floettmann JE, Ward K, Rickinson AB, Rowe M (1996) Cytostatic effect of Epstein–Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Virology 223:29–40PubMedCrossRef Floettmann JE, Ward K, Rickinson AB, Rowe M (1996) Cytostatic effect of Epstein–Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Virology 223:29–40PubMedCrossRef
89.
Zurück zum Zitat Deng W, Pang PS, Tsang CM, Hau PM, Yip YL, Cheung ALM, Tsao SW (2012) Epstein–Barr virus-encoded latent membrane Protein 1 Impairs G2 checkpoint in human nasopharyngeal epithelial cells through defective Chk1 activation. PLoS ONE 7:e39095PubMedCrossRef Deng W, Pang PS, Tsang CM, Hau PM, Yip YL, Cheung ALM, Tsao SW (2012) Epstein–Barr virus-encoded latent membrane Protein 1 Impairs G2 checkpoint in human nasopharyngeal epithelial cells through defective Chk1 activation. PLoS ONE 7:e39095PubMedCrossRef
90.
Zurück zum Zitat Gruhne B, Kamranvar SA, Masucci MG, Sompallae R (2009) EBV and genomic instability—a new look at the role of the virus in the pathogenesis of Burkitt’s lymphoma. Sem Cancer Biol 19:394–400CrossRef Gruhne B, Kamranvar SA, Masucci MG, Sompallae R (2009) EBV and genomic instability—a new look at the role of the virus in the pathogenesis of Burkitt’s lymphoma. Sem Cancer Biol 19:394–400CrossRef
91.
Zurück zum Zitat Gruhne B, Sompallae R, Marescotti D, Kamranvar SA, Gastaldello S, Masucci MG (2009) The Epstein–Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc Natl Acad Sci USA 106:2313–2318PubMedCrossRef Gruhne B, Sompallae R, Marescotti D, Kamranvar SA, Gastaldello S, Masucci MG (2009) The Epstein–Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc Natl Acad Sci USA 106:2313–2318PubMedCrossRef
92.
Zurück zum Zitat Kamranvar SA, Gruhne B, Szeles A, Masucci MG (2007) Epstein–Barr virus promotes genomic instability in Burkitt’s lymphoma. Oncogene 26:5115–5123PubMedCrossRef Kamranvar SA, Gruhne B, Szeles A, Masucci MG (2007) Epstein–Barr virus promotes genomic instability in Burkitt’s lymphoma. Oncogene 26:5115–5123PubMedCrossRef
93.
Zurück zum Zitat Li JH, Chia M, Shi W, Ngo D, Strathdee CA, Huang D, Klamut H, Liu FF (2002) Tumor-targeted gene therapy for nasopharyngeal carcinoma. Cancer Res 62:171–178PubMed Li JH, Chia M, Shi W, Ngo D, Strathdee CA, Huang D, Klamut H, Liu FF (2002) Tumor-targeted gene therapy for nasopharyngeal carcinoma. Cancer Res 62:171–178PubMed
94.
Zurück zum Zitat Zuo Y, Wu J, Xu Z, Yang S, Yan H, Tan L, Meng X, Ying X, Liu R, Kang T, Huang W (2011) Minicircle-oriP-IFNγ: a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinoma. PLoS One. 6e19407 Zuo Y, Wu J, Xu Z, Yang S, Yan H, Tan L, Meng X, Ying X, Liu R, Kang T, Huang W (2011) Minicircle-oriP-IFNγ: a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinoma. PLoS One. 6e19407
95.
Zurück zum Zitat Carbone M, Klein G, Gruber J, Wong M (2004) Modern criteria to establish human cancer etiology. Cancer Res 64:5518–5524PubMedCrossRef Carbone M, Klein G, Gruber J, Wong M (2004) Modern criteria to establish human cancer etiology. Cancer Res 64:5518–5524PubMedCrossRef
96.
Zurück zum Zitat zur Hausen H (2012) Red meat consumption and cancer: reasons to suspect involvement of bovine infectious factors in colorectal cancer. Int J Cancer 130:2475–2483PubMedCrossRef zur Hausen H (2012) Red meat consumption and cancer: reasons to suspect involvement of bovine infectious factors in colorectal cancer. Int J Cancer 130:2475–2483PubMedCrossRef
Metadaten
Titel
An update on viral association of human cancers
verfasst von
Xiangning Zhang
Zhe Zhang
Biying Zheng
Zhiwei He
Gösta Winberg
Ingemar Ernberg
Publikationsdatum
01.07.2013
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 7/2013
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-013-1623-9

Weitere Artikel der Ausgabe 7/2013

Archives of Virology 7/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.